The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term follow-up from STAMP, a phase II trial, evaluating sipuleucel-T and concurrent (CON) vs sequential (SEQ) abiraterone acetate + prednisone in metastatic castration-resistant prostate cancer patients (pts).
 
Eric Jay Small
Research Funding - Janssen (Inst)
 
Raymond S. Lance
Speakers' Bureau - Medivation
 
Charles H. Redfern
Research Funding - Sharp healthcare
 
Frederick E. Millard
No Relationships to Disclose
 
Thomas A. Gardner
No Relationships to Disclose
 
Nancy Ann Dawson
Honoraria - Amgen; Astellas Pharma; Bayer; Eisai; Genentech/Roche; Janssen Biotech; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Janssen Scientific Affairs
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Dendreon; Eisai; Genentech/Roche; Janssen Biotech; Novartis; Pfizer; Sanofi
Research Funding - Acceleron Pharma (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Pfizer (Inst); Roche/Genentech (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Lawrence Fong
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Oncology; Oncosec (Inst); Roche/Genentech (Inst)
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medical
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation/Astellas
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation/Astellas
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen (Inst); Medivation/Astellas (Inst); Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; dendreon; Janssen; Medivation/Astellas; Spectrum Pharmaceuticals
 
John M. Corman
No Relationships to Disclose
 
Luke T. Nordquist
No Relationships to Disclose
 
Myron I Murdock
No Relationships to Disclose
 
Brendan D. Curti
Honoraria - Prometheus
Speakers' Bureau - Prometheus
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Prometheus (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Agonox; MedImmune; Prometheus
 
Nancy N. Chang
Employment - Dendreon
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
 
Neal D. Shore
Consulting or Advisory Role - Bayer; Dendreon; Ferring; Janssen Scientific Affairs; Medivation/Astellas; Sanofi; Takeda; Tolmar